Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet comparative studies have not identified optimal therapy. METHODS: We conducted an individual patient-level quantitative review of randomized trials for treatment of IC and to assess the impact of host-, organism-, and treatment-related factors on mortality and clinical cure. Studies were identified by searching computerized databases and queries of experts in the field for randomized trials comparing the effect of ≥2 antifungals for treatment of IC. Univariate and multivariable analyses were performed to determine factors associated with patient outcomes. RESULTS: Data from 1915 patients were obtained from 7 trials. Overall mortality among patients in the entire data set was 31.4%, and the rate of treatment success was 67.4%. Logistic regression analysis for the aggregate data set identified increasing age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), the Acute Physiology and Chronic Health Evaluation II score (OR, 1.11; 95% CI, 1.08-1.14; P = .0001), use of immunosuppressive therapy (OR, 1.69; 95% CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01) as predictors of mortality. Conversely, removal of a central venous catheter (CVC) (OR, 0.50; 95% CI, .35-.72; P = .0001) and treatment with an echinocandin antifungal (OR, 0.65; 95% CI, .45-.94; P = .02) were associated with decreased mortality. Similar findings were observed for the clinical success end point. CONCLUSIONS: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Two RCTs have been published (119, 120); one failed to achieve a difference in time-to-antimicrobials between arms (120) and the other found no significant difference in mortality despite a 90-minute difference in median time interval to antimicrobial administration (119).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomized studies (120,263,264).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Treatment with FLC often fails despite isolates being drug susceptible when tested in vitro, and rates of persistent candidemia are often higher in patients treated with FLC rather than with echinocandins 58 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [58]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [130]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“mon cause of nosocomial bloodstream infection [1–4].”
BackgroundMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cited by
Items 601–700 of 804
Dupont, D., Tirard-Collet, P., Persat, F., Ménotti, J., Josse, E., Wallon, M., & Pichon, M. (2019) · Medical Mycology · doi:10.1093/mmy/myz080 · Cited by 3
Preventing Candida albicans biofilm formation using aromatic-rich piperazines
Simon, G., Bérubé, C., Paquet-Côté, P.-A., Grenier, D., & Voyer, N. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115810 · Cited by 3
Candidemia in patients with head and neck cancer: mortality and a novel risk factor
Uraguchi, K., Makino, T., Kariya, S., Noda, Y., Marunaka, H., Doi, A., Kozakura, K., Takao, S., & Ando, M. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07010-9 · Cited by 3
Schuster, J. E., & Fisher, B. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64198-2.00035-x · Cited by 4
A Review of Cutaneous Diseases Observed in Solid Organ Transplant Recipients.
Fronek, L. F., Giansiracusa, D., Nourmohammadi, N., Johnson, C., Yelich, A., & Hogan, D. J. (2022) · PubMed · Cited by 3
Ueda, T., Kakeya, H., Yoshida, K., Hisato, A., Ukimura, A., Ogawa, T., Nakajima, K., Iijima, K., Nagao, M., Tsuchido, Y., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf078 · Cited by 3
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_20 · Cited by 4
Self-citationCaeiro, J. P., & Riera, F. O. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0171-9 · Cited by 3
Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship
Sofjan, A. K., Musgrove, R. J., & Garey, K. W. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0257-2 · Cited by 3
Update on the “Choosing Wisely” initiative in infectious diseases in Germany
the Choosing Wisely (Klug entscheiden) DGI Working Group, Draenert, R., & Jung, N. (2020) · Infection · doi:10.1007/s15010-020-01400-z · Cited by 3
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates
Sass, G., Larwood, D. J., Martinez, M., & Stevens, D. A. (2023) · Mycoses · doi:10.1111/myc.13569 · Cited by 3
Effect of the implementation of clinical guidelines on management of candidemia in elderly patients
López, N. V., Parra, J. C., Serrano, A. M., Villanueva, A. G., Moral, S. D. L. F., Moreno‐Torres, V., Múñez, E., & Ramos, A. (2023) · Mycoses · doi:10.1111/myc.13621 · Cited by 2
Salmani, T. A., Mahdi, A. S., Balkhair, A., Al-Siyabi, T., & Wazir, H. B. (2025) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.2832 · Cited by 3
Zhang, L., Zhang, Q., Ma, W., Chu, Z., Xu, L., Xing, H., Wang, J., Lin, J., & Liu, Z. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s494985 · Cited by 2
Kang, S., Han, S. H., Kim, G., Son, H., Won, E. J., Sung, H., Kim, M., Chang, E., Bae, S., Jung, J., et al. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.06.002 · Cited by 2
Microbial infections in lymphocytic leukemia: A 12 year analysis in the Saudi population
Khateb, A. M., Barefah, A., Doha, Z. O., Albakri, M. M., Radhwi, O., Algiraigri, A. H., & Azhar, E. I. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.103005 · Cited by 2
Badrane, H., Clancy, C. J., & Nguyen, M. H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01545-25 · Cited by 2
Zhou, X., Hilk, A. L., Solis, N. V., Scott, N. E., Zajac, C., Filler, S. G., & Selmecki, A. M. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003631 · Cited by 2
Antifungal PK/PD in the Critically Ill
Brüggemann, R. J. M., de Lange, D. W., & Alffenaar, J. C. (2017) · Springer eBooks · doi:10.1007/978-981-10-5336-8_11 · Cited by 2
Invasive yeast infection in patient with Acute pancreatitis
Janka, V. (2017) · Imaging Journal of Clinical and Medical Sciences · doi:10.17352/2455-8702.000034 · Cited by 2
Clancy, C. J., & Nguyen, M. H. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.03.017 · Cited by 2
Indication des traitements antifongiques (hors hématologie). Que montrent les données ?
Huette, P., & Dupont, H. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.03.004 · Cited by 2
Dabade, S. J., Mandloi, D., Bajaj, A. V., & Dhingra, N. (2020) · International Journal of Quantitative Structure-Property Relationships · doi:10.4018/ijqspr.2020100101 · Cited by 2
Andes, D. R. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab015 · Cited by 2
Self-citationCandidemia in Older Adults: What Are the Risk Factors for Mortality?
Taşar, P. T., Karaşahin, Ö., Karahan, B., Kızıltunç, H. S., & Albayrak, A. (2022) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20229809 · Cited by 2
Chen, Y.-C., Ho, M., Chao, W., & Chang, C. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823000894 · Cited by 2
Candidemia Surveillance and Impact on Non-neutropenic Critically Ill Patients
Zimmerman, L. H., Dolman, H. S., Faris, J. J., Park, L., Mynatt, R. P., Zimmerman, W. B., Baylor, A. E., Tyburski, J. G., & Wilson, R. F. (2024) · Cureus · doi:10.7759/cureus.73155 · Cited by 2
Biofilm Formation and its Impact on Antifungal Therapy
Müller, F. C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0194-x · Cited by 3
Management of Candida infections in liver transplant recipients: current perspectives
Lingegowda, P. B., & Tan, B. H. (2014) · Transplant Research and Risk Management · doi:10.2147/trrm.s38620 · Cited by 2
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2013.05.016 · Cited by 3
Factors influencing recovery in patients with hemoblastoses and candidemia
Klyasova, G. A., Блохина, Е. В., Gracheva, A., Кравченко, С. К., Parovichnikova, E. N., Александрович, О. В., Korobova, A. G., Galstyan, G. M., & Kulikov, S. M. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587777-87 · Cited by 2
Catheter Removal Does Matter but Should Be Individualized for Patients with Candidemia
Yin, M., Li, C., Wu, D., & Wang, H. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.7205 · Cited by 2
Fungal Infections After Hematopoietic Cell Transplantation
Marr, K. A. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch86 · Cited by 2
Isavuconazole: Has It Saved Us? A Pharmacotherapy Review and Update on Clinical Experience
McCreary, E. K., Schulz, L. T., & Lepak, A. J. (2017) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-017-0133-9 · Cited by 3
Mikdachi, H. F., & Spann, E. (2019) · Cureus · doi:10.7759/cureus.4349 · Cited by 2
Antifungal Agents in the Treatment of Candidosis and Susceptibility Tests
Altıntaş, S. N., & Şahiner, F. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2021.32 · Cited by 2
Abdel‐Haq, N., Smith, S. M., & Asmar, B. I. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2013807 · Cited by 2
Bustamante, B., Hidalgo, J. A. M., & Campos, P. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_2 · Cited by 3
Fungaemia and disseminated infection
Lester, R., & Rex, J. H. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0025 · Cited by 2
Self-citationRola, A., Potok, P., Mos, M., Gumienna‐Kontecka, E., & Potocki, S. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c02080 · Cited by 3
Ostrosky-Zeichner, L. L., & Sobel, J. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-35803-6_9 · Cited by 2
Self-citationErratum to: An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2014) · Infection · doi:10.1007/s15010-013-0577-x · Cited by 2
Lashof, A. M. L. O., & Vogelaers, D. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit061 · Cited by 2
Schena, N. C., Baker, K. M., Stark, A. A., Thomas, D. P., & Cleary, I. A. (2026) · Folia Microbiologica · doi:10.1007/s12223-025-01288-y · Cited by 1
Impact of select risk factors on treatment outcome in adults with candidemia
Hill, B. K., Drew, R. H., & Wilson, D. T. (2019) · Pharmacy Practice · doi:10.18549/pharmpract.2019.3.1561 · Cited by 1
Copper and silver doped in CdTe quantum dots: C. albicans and C. tropicalis antifungal nanomaterials
Tirado-Guízar, A., Pina‐Luis, G., Trujillo-Navarrete, B., & Paraguay‐Delgado, F. (2023) · Materials Research Express · doi:10.1088/2053-1591/acca6c · Cited by 1
Pek, Z., & Bork, J. T. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00468-y · Cited by 1
Pietrobom, P. M. P., Truda, V. S. S., Fernández‐Ruiz, M., Gutiérrez, M. G., Sukiennik, T., Santos, D. W. D. C. L., Valerio, M., Gioia, F., Rodríguez‐Góncer, I., Giacobbe, D. R., et al. (2023) · Mycoses · doi:10.1111/myc.13669 · Cited by 1
Frecuencia y factores de riesgo para fungemia por especies de Candida
Henao, S. B., Gómez, J. R. M., Restrepo, C. A. A., Rincón, C. I. G., Arboleda-Arias, N., Pérez-Giraldo, P. A., Ospina-Chaparro, L., Ruiz-Giraldo, S., & Hidrón-Botero, A. (2023) · Acta Médica Colombiana · doi:10.36104/amc.2024.2734 · Cited by 3
Silva, P. A., Souza, A. A., de Oliveira, G. M., Ramada, M. H. S., Hernández, N. V., Mora-Montes, H. M., Bueno, R. V., Martins-de-Sa, D., de Freitas, S. M., Felipe, M. S. S., et al. (2024) · Fungal Biology and Biotechnology · doi:10.1186/s40694-024-00174-5 · Cited by 1
Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis
Korem, M., Reich, S., Rahav, G., Yahav, D., Weinberger, M., Novikov, A., Mizrahi, N., & Ben‐Ami, R. (2025) · Mycoses · doi:10.1111/myc.70017 · Cited by 1
Filippatos, F., Karava, V., Kakleas, K., Santou, A., & Michos, A. G. (2025) · Cureus · doi:10.7759/cureus.87740 · Cited by 1
Kumar, A., Singh, N., Das, A., & Agarwal, J. (2025) · Cureus · doi:10.7759/cureus.90131 · Cited by 4
Yang, X., Liu, T., Lei, J., Cai, W., Mai, Y., & Tang, X.-K. (2025) · Mycoses · doi:10.1111/myc.70106 · Cited by 1
Recent Advances in Pediatric Infectious Diseases: A Review of Diagnostic and Therapeutic Strategies
Krishna Vamshy, J., Varshini, M., Rathore, N., Patil, R., Sinha, J., & Bhattacharjee, A. (2025) · Cureus · doi:10.7759/cureus.94523 · Cited by 1
Endo, A., Mikawa, T., Ishibe, T., Nakane, Y., Asakawa, D., Kido, S., Fujimori, K., Takatori, M., Natsume, Y., Matsumoto, K., et al. (2026) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2025.10380 · Cited by 1
Colombo, A. L., Magri, M. M. C., Carlesse, F. A. D. M. C., Falci, D. R., Garnica, M., Santos, D. W. D. C. L., Queiroz‐Telles, F., & Pasqualotto, A. C. (2026) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2026.105946 · Cited by 2
Mendoza, A. R., Ramírez, A. P., Encinales, L., Madiedo, O., Carrillo-Encinales, M., Bolívar, J. P. D., Cuellar, J. F. R., Méndez, J. A. U., Moreno-Perilla, Z., & Zambrano, R. J. (2026) · Journal of Fungi · doi:10.3390/jof12080608 · Cited by 1
Recent Advancements in Combinational Antifungal Therapy and Immunotherapy
Rathore, S. S., Ramakrishnan, J., & Raman, T. (2016) · Springer eBooks · doi:10.1007/978-81-322-2782-3_6 · Cited by 2
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_20-1 · Cited by 2
Self-citationImpact of echinocandins as first-choice therapy in cardiothoracic high-risk patients with candidemia
Langebartels, G., Choi, Y., Catteleans, J., & Wahlers, T. (2013) · Critical Care · doi:10.1186/cc12023 · Cited by 1
Strategien bei Versagen einer antimykotischen Therapie auf Intensivstation
Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1
Echinocandins for Primary Therapy of Candidemia: Time for a Paradigm Shift?
Colombo, R. E., & Vázquez, J. A. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0215-9 · Cited by 2
Improving maintenance of critical care land and aeromedical transfer equipment
Ashton-Cleary, D., & Boyd, N. (2013) · Critical Care · doi:10.1186/cc12221 · Cited by 1
Invasive Candidiasis in the Intensive Care Setting
GASPERI, A. D., Cozzi, P., & Colombo, S. (2013) · Springer eBooks · doi:10.1007/978-88-470-5529-2_13 · Cited by 1
Intensive Care Units: at the Frontline of Infectious Disease
Montravers, P., & Lyon, S. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0201-2 · Cited by 1
Jiman-Fatani, A. A., Meawed, T. E., & El-Hossary, D. (2015) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/770 · Cited by 1
Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia
Kubiak, D. W., Farmakiotis, D., Arons, V., Hollins, R. M., Rostas, S. E., Weiser, L. M., Baden, L. R., Marty, F. M., & Koo, S. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.11.018 · Cited by 2
Vaccination Against Fungal Diseases: Lessons from Candida albicans
Sampaio, P., & Pais, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-50842-9_10 · Cited by 1
Moreira, J., Peixoto, T. M., Abrantes, J. A., Olival, S., Correia, M. G., de Farias, L. P., Garrido, R. Q., de Freitas, M. B., Felipe, A. R., & Lamas, C. D. C. (2018) · Heart Vessels and Transplantation · doi:10.24969/hvt.2017.44 · Cited by 1
New Molecular Method for Detection of Candidemia, but Don’t Forget the Blood Cultures
Hawley, H. B. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1101 · Cited by 1
PCR-Based Methods for the Diagnosis of Invasive Candidiasis: Are They Ready for Use in the Clinic?
Nguyen, M. H., & Clancy, C. J. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0313-1 · Cited by 1
Choudhury, S. (2018) · Pathology · doi:10.1016/j.pathol.2018.07.010 · Cited by 1
Candida Infections in Hematopoietic and Solid Organ Transplant Recipients
Freifeld, A. G., & Kauffman, C. A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_32 · Cited by 1
What Is New in Candida Infections? T2Candida, Antifungal Stewardship, and Candida auris
Clancy, C. J., & Nguyen, M. H. (2020) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-020-00209-6 · Cited by 1
Er, H., Özyurt, Ö. K., Özhak, B., Yazısız, H., Öngüt, G., Sarıtaş, Z. E., Dönmez, L., Çolak, D., Günseren, F., & Öğünç, D. (2020) · Mikrobiyoloji Bulteni · doi:10.5578/mb.69832 · Cited by 1
Echinocandins in Pediatric Invasive Candidiasis and the Challenges of Antifungal Use in Children
Yeoh, D. K., Blyth, C. C., & McMullan, B. J. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab039 · Cited by 1
Ferrer, R., de la Cámara, A. G., Ramos, I. J., Quindós, G., & Tejerina, M. T. (2013) · Actualidad en farmacología y terapéutica · Cited by 4
Cottom, L., & McPhee, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00133-x · Cited by 1
Otto, W. R., Steinbach, W. J., & Fisher, B. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00243-3 · Cited by 1
A case of treatment of a fungal periprosthetic infection with a carbon-coated implant
Игоревич, М. Л., Николаев, Н. С., Lyubimova, L. V., Preobrazhenskaya, E. V., & Efimov, D. N. (2022) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2022.6.case.1 · Cited by 2
Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice
Schrevens, S., Torelli, R., Sanguinetti, M., & Sanglard, D. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_17 · Cited by 1
A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin
Mishra, A., Usha, P., & Sabareesh, V. (2024) · Springer eBooks · doi:10.1007/978-981-99-5696-8_22 · Cited by 1
Hisano, H., Shoji, K., Matsui, T., Kato, H., Fukui, K., Kano, M., Yamada, Y., Gocho, Y., & Ishiguro, A. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.102600 · Cited by 1
Kawasaki, K., Sawai, T., Inadomi, Y., Morimitsu, S., Ikeda, T., Yoshioka, S., Matsuo, N., Kadota, J., Yanagihara, K., & Mukae, H. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102662 · Cited by 2
Physico-chemical characteristics and antimicrobial studies of silver doped hydroxyapatite
Predoi, D., Predoi, M. V., Elkettani, M. E., Leduc, D., Iconaru, S. L., Ciobanu, C. S., Buton, N., Petre, C. C., & Prodan, A. M. (2018) · AIP conference proceedings · doi:10.1063/1.5024184 · Cited by 1
Lest we forget, fungi are flourishing and fatal in man – and now the fear of resistance!
(2014) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2014.11441577 · Cited by 2
Reply to Oude Lashof and Vogelaers
Safdar, N., Baddley, J. W., & Andes, D. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit062 · Cited by 1
Self-citationManagement of Candidemia: Getting Better, But Not There Yet*
Leroy, O., & Alfandari, S. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000261 · Cited by 1
Far-reaching Conclusions Based on Weak and Missing Data
Anaissie, E. J., & Nucci, M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis521 · Cited by 1
Susceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0135 · Cited by 3
Susceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0135 · Cited by 1
Rezafungin: an opportunity to personalize the treatment of patients with candidemia
Honoré, P. M., Cornely, O. A., & Soriano, À. (2025) · Critical Care · doi:10.1186/s13054-025-05519-z · Cited by 1
Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics
Rodrigues, C. F., & Černáková, L. (2025) · Journal of Fungi · doi:10.3390/jof11100693 · Cited by 1
De la bonne utilisation des antifongiques systémiques en réanimation
Timsit, J., Potton, L., Lugosi, M., Minet, C., Hamidfar-Roy, R., Ara-Somohano, C., Bonadona, A., & Schwebel, C. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_7
Echinocandins for candidemia: a rational choice
Menichetti, F., & Tagliaferri, E. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i2s.872
Blennow, O. (2014) · Figshare
Jaijakul, S., & Ostrosky-Zeichner, L. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis906
Reply to Anaissie and Nucci and to Cisneros et al
Andes, D. R., Safdar, N., Baddley, J. W., Kullberg, B. J., & Pappas, P. G. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis523 · Cited by 1
Self-citationCANDIDA YEASTS AND CARCINOGENIC ACETALDEHYDE IN UPPER DIGESTIVE TRACT CARCINOGENESIS
Nieminen, M. T. (2014) · Helda - University of Helsinki Institutional Repository
Metadata
- Authors
- Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group
- Affiliations
- University of Wisconsin–Madison (US)
- University of Alabama at Birmingham (US)
- The University of Queensland (AU)
- Rutgers, The State University of New Jersey (US)
- AstraZeneca (United States) (US)
- Wayne State University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 54
- Issue
- 8
- Pages
- 1110-1122
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134827411
- Cited by
- 793
- References
- 72
- Citations by year
- 2026: 20 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 42 · 2021: 64 · 2020: 81 · 2019: 46 · 2018: 71 · 2017: 69 · 2016: 58 · 2015: 62 · 2014: 60 · 2013: 54 · 2012: 28
- FWCI
- 45.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, candidemia, antifungal therapy, echinocandins, central venous catheter removal, mortality, clinical cure, risk factors, immunosuppression, Candida tropicalis, APACHE II score
- MeSH terms
- Adult, Aged, Antifungal Agents, Catheterization, Central Venous, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.